Health & Behavior

Research

The Latest

Comprehensive Stroke Center Earns Gold Recognition for Patient Care

When someone experiences a major stroke, almost two million nerve cells in the brain die each minute, emphasizing the need for rapid treatment. Stroke patients who receive life-saving interventions more quickly have a higher chance of recovery. A recent data analysis showed the Comprehensive Stroke Center at UC San Diego Medical Center exceeded national average treatment times, and as a result, has received a “Get With The Guidelines-Stroke Gold Plus Quality Achievement Award” from The American Heart Association and American Stroke Association (AHA/ASA).

UC San Diego’s Thomas E. Levy Among Recipients of President’s Research Catalyst Award

Levy's $1.07 million project will leverage the recently-announced Pacific Research Platform to curate, analyze and visualize 3D data from at-risk archaeological sites in the Middle East.

New Method Allows Scientists to Screen Natural Products for Antibiotics

Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.

UC San Diego Receives Michael J. Fox Foundation Grant to Identify Parkinson’s Biomarkers

Parkinson’s disease is difficult to diagnose, particularly in its early stages. Now, researchers at University of California, San Diego School of Medicine – aided by a $375,000 grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) – hope to improve the prospects of early diagnosis by identifying a biological signpost in the blood.

Existing Compound Holds Promise for Reducing Huntington’s Disease Progression

Currently, there is no treatment to halt the progression of Huntington’s disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.

Addiction Treatment Innovation Launches at the Qualcomm Institute

The Clinical Addiction Recovery Institute (C.A.R.I.), has announced that it will join the University of California, San Diego community as one of the newest members of the Qualcomm Institute Innovation Space (QIIIS).